Suppr超能文献

肾小管损伤标志物对预测2型糖尿病合并蛋白尿患者肾功能不全进展的价值:福冈糖尿病登记研究

Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry.

作者信息

Ide Hitoshi, Iwase Masanori, Ohkuma Toshiaki, Fujii Hiroki, Komorita Yuji, Oku Yutaro, Higashi Taiki, Yoshinari Masahito, Nakamura Udai, Kitazono Takanari

机构信息

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Diabetes Center and Clinical Research Center, Hakujyuji Hospital, Fukuoka, Japan.

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Diabetes Center and Clinical Research Center, Hakujyuji Hospital, Fukuoka, Japan.

出版信息

Diabetes Res Clin Pract. 2022 Apr;186:109840. doi: 10.1016/j.diabres.2022.109840. Epub 2022 Mar 21.

Abstract

AIMS

We prospectively investigated the association of urinary tubule injury markers with estimated glomerular filtration rate (eGFR) decline in Japanese patients with type 2 diabetes.

METHODS

Urinary kidney injury molecule 1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty-acid-binding protein (L-FABP), and urinary albumin-to creatinine ratio (UACR) were measured in 2,685 participants with type 2 diabetes. Renal outcomes were ≥ 30% decline in eGFR from the baseline and annual eGFR decline for 5 years.

RESULTS

In normoalbuminuric participants, no tubular markers were associated with ≥ 30% decline in eGFR or annual eGFR changes. In those with UACR ≥ 30 mg/gCr, hazard ratios for ≥ 30% eGFR decline were 1.37 (95% confident interval (CI) 1.07-1.75) for urinary KIM-1 (>1.5 µg/gCr), 1.46 (95% CI 1.13-1.66) for urinary NGAL (>16.4 µg/gCr), and 1.26 (95% CI 0.94-1.66) for urinary L-FABP (>12.5 µg/gCr), 2.61 (95% CI 1.64-4.17) for the combination of 3 tubular markers above the cutoff after multivariable adjustments including UACR and eGFR.

CONCLUSIONS

The current study demonstrated that urinary tubule injury markers and their combination were significant predictors for the future eGFR decline in those with type 2 diabetes and albuminuria independently of UACR and eGFR. Urinary tubular markers may be useful to identify high-risk patients with albuminuria.

摘要

目的

我们前瞻性地研究了日本2型糖尿病患者肾小管损伤标志物与估计肾小球滤过率(eGFR)下降之间的关联。

方法

对2685名2型糖尿病参与者测量了尿肾损伤分子1(KIM-1)、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、肝型脂肪酸结合蛋白(L-FABP)以及尿白蛋白与肌酐比值(UACR)。肾脏结局为eGFR较基线下降≥30%以及5年的年度eGFR下降情况。

结果

在正常白蛋白尿参与者中,没有肾小管标志物与eGFR下降≥30%或年度eGFR变化相关。在UACR≥30mg/gCr的参与者中,对于eGFR下降≥30%,尿KIM-1(>1.5μg/gCr)的风险比为1.37(95%置信区间(CI)1.07 - 1.75),尿NGAL(>16.4μg/gCr)为1.46(95%CI 1.13 - 1.66),尿L-FABP(>12.5μg/gCr)为1.26(95%CI 0.94 - 1.66),在多变量调整(包括UACR和eGFR)后,上述3种高于临界值的肾小管标志物组合的风险比为2.61(95%CI 1.64 - 4.17)。

结论

当前研究表明,肾小管损伤标志物及其组合是2型糖尿病和蛋白尿患者未来eGFR下降的重要预测指标,独立于UACR和eGFR。肾小管标志物可能有助于识别蛋白尿高危患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验